KADCYLA (Genentech, Inc.)
Welcome to the PulseAid listing for the KADCYLA drug offered from Genentech, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | ADO-TRASTUZUMAB EMTANSINE |
| SUBSTANCE NAME: | ADO-TRASTUZUMAB EMTANSINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2013-02-22 |
| END MARKETING DATE: | 0000-00-00 |
KADCYLA HUMAN PRESCRIPTION DRUG Details:
| Item Description | KADCYLA from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2013-02-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50242-087_41031d63-37c7-481b-a13d-ea3cd2cfcdeb |
| PRODUCT NDC: | 50242-087 |
| APPLICATION NUMBER: | BLA125427 |
Other ADO-TRASTUZUMAB EMTANSINE Pharmaceutical Manufacturers / Labelers:
